Embolotherapy Market Report 2026

Embolotherapy Market Overview

• Embolotherapy market size has reached to $4.84 billion in 2025 • Expected to grow to $7.33 billion in 2030 at a compound annual growth rate (CAGR) of 8.6% • Growth Driver: Rising Preference For Minimally Invasive Procedures Driving Market Growth • Market Trend: Introduction Of Absorbable Embolic Systems • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Embolotherapy Market?

Embolotherapy is a minimally invasive medical procedure involving intentionally blocking blood vessels to treat various medical conditions. It is achieved by injecting embolic agents, such as microspheres, coils, gels, or liquid embolic, into targeted blood vessels to cut off blood supply to abnormal tissues or structures. Embolotherapy is a highly targeted and less invasive alternative to traditional surgery, often performed by interventional radiologists to improve patient outcomes with minimal recovery time. The main product types in the embolotherapy are embolization coils, embolic agents, detachable balloons, embolic plug systems, and support devices. Embolization coils are small, flexible devices used in embolotherapy to block blood flow in targeted blood vessels for treating conditions such as aneurysms, tumors, and vascular malformations. These products are used for various applications, including oncology, peripheral vascular diseases, urology and nephrology, neurology, and gastrointestinal (GIT) disorders. The procedures involved in embolotherapy include transcatheter arterial embolization (TAE), transcatheter arterial radioembolization (TARE) or selective internal radiation therapy (SIRT), and transarterial chemoembolization (TACE). End users of embolotherapy products include ambulatory surgical centers, hospitals and clinics, and other healthcare providers.

What Is The Embolotherapy Market Growth Forecast?

The embolotherapy market size is expected to see strong growth in the next few years. It will grow to $7.33 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising oncology patient population, demand for organ-preserving treatments, innovation in liquid embolic agents, expansion of ambulatory surgical centers, improved imaging and navigation systems. Major trends in the forecast period include rising adoption of minimally invasive procedures, increasing use of image-guided interventional therapies, growing demand for targeted cancer treatments, technological advancements in embolic materials, expansion of interventional radiology services.

What Is The Driver Of The Embolotherapy Market?

The rising preference for minimally invasive procedures is expected to propel the growth of the embolotherapy market going forward. Minimally invasive procedures refer to cosmetic treatments that require little to no surgical intervention, typically involving minimal downtime and lower risks. The rising preference for minimally invasive procedures is driven by faster recovery, reduced pain, more minor scars, lower complication risks, and technological advances. Embolotherapy enhances minimally invasive procedures by selectively blocking blood flow to targeted vessels, reducing bleeding, treating tumors, and managing vascular abnormalities with greater precision and fewer complications. For instance, in September 2023, according to the American Society of Plastic Surgeons, a US-based non-profit organization, cosmetic minimally invasive procedures grew by 7% in 2023, reaching 25,442,640, up from 23,672,269 in 2022. Therefore, the rising preference for minimally invasive procedures is driving the growth of the embolotherapy industry.

Key Players In The Global Embolotherapy Market

Major companies operating in the embolotherapy market are Boston Scientific Corporation, Terumo Medical Corporation, Medtronic PLC, Johnson And Johnson, Sirtex Medical, Abbott Laboratories, Acandis GmbH, Balt Group LLC, Penumbra Inc, Merit Medical Systems, Meril Life Sciences Pvt. Ltd., Guerbet, Cardiva, Rapid Medical, Emboline Inc, Microport Scientific, Embolx Inc, Lepu Medical Technology Co Ltd, WEGO HEALTHCARE (SHENZHEN) CO. LTD, Varian Medical Systems Inc.

Global Embolotherapy Market Trends and Insights

Major companies operating in the embolotherapy market are focusing on developing innovative products such as absorbable embolics systems to enhance patient outcomes and expand treatment options. Absorbable embolic systems refer to bioresorbable materials used in embolization procedures to block blood flow to target tissues, such as tumors or aneurysms, while gradually degrading within the body over time. For instance, in January 2025, Instylla Inc., a US-based medical equipment manufacturing company, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Tembo embolic system, a bioresorbable embolization agent made of irregularly shaped, dry-gelatin particles sized between 85 and 255 µm. The system is designed to embolize hypervascular tumors and occluding blood vessels in the peripheral vasculature. According to Instylla, Tembo offers advantages such as easy preparation, high visibility, and the ability to densely pack treated vessels densely, potentially improving existing permanent embolic solutions.

What Are Latest Mergers And Acquisitions In The Embolotherapy Market?

In November 2024, Merit Medical Systems Inc., a US-based healthcare technology company, acquired Lead Management Portfolio from Cook Medical for approximately $210 million. With this acquisition, Merit Medical Systems, Inc. seeks to strengthen its electrophysiology (EP) and cardiac rhythm management (CRM) business by expanding its product portfolio and market reach. Cook Medical LLC is a US-based medical device company that specializes in providing embolization coils.

What Defines the Embolotherapy Market?

The embolotherapy market consists of revenues earned by entities by providing services such as catheter-based embolization, flow diversion therapy, tumor embolization, uterine fibroid embolization, and endovenous embolization for varicose veins. The market value includes the value of related goods sold by the service provider or included within the service offering. The embolotherapy market also includes sales of microcatheters, liquid embolic agents, particle embolic agents, balloon occlusion devices, and flow diverters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Embolotherapy Market Report 2026?

The embolotherapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the embolotherapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.